0 results available. Select is focused ,type to refine list, press Down to open the menu,
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company provides immunolo...
The following section summarizes insights on Sanofi L's PEG Ratio:
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to PEG Ratio in the valuation category include:
A heuristic used to measure the level of earnings growth reflected in a stock's market price.
PEG Ratio is a valuation metric for determining the relative trade-off between the price of a stock, the earnings per share (EPS), and the company’s trailing EPS growth rate. A lower ratio is considered ‘better’ (cheaper) and a higher ratio is ‘worse’ (expensive).
PEG Ratio = (P/E Ratio) / Trailing EPS Growth Rate*
*Note, the growth rate is multiplied by 100 before this calculation.
Applying this formula, Sanofi’s PEG Ratio is calculated below:
P/E Ratio [ 23.0 ]
(/) EPS Growth Rate * 100 [ 2.9 ]
(=) PEG Ratio [ 7.8 ]
The tables below summarizes the trend in Sanofi’s PEG Ratio over the last five years:
| Date | P/E Ratio | EPS Growth Rate | PEG Ratio |
|---|---|---|---|
| 2020-12-31 | 8.8 | 264.4 | 0.0 |
| 2021-12-31 | 18.0 | −45.0 | −0.4 |
| 2022-12-31 | 17.6 | 4.0 | 4.3 |
| 2023-12-31 | 12.4 | 41.5 | 0.3 |
| 2024-12-31 | 23.0 | 2.9 | 7.8 |